As of 2025-07-08, the Relative Valuation of SAGE Therapeutics Inc (SAGE) is (166.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.17 USD, the upside of SAGE Therapeutics Inc based on Relative Valuation is -1911.4%.
The range of the Relative Valuation is (139.34) - (224.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.1x - 39.7x | 26.6x |
| Forward P/E multiples | 24.6x - 47.4x | 32.1x |
| Fair Price | (139.34) - (224.57) | (166.11) |
| Upside | -1619.5% - -2548.9% | -1911.4% |
| Date | P/E |
| 2025-07-07 | -1.62 |
| 2025-07-03 | -1.63 |
| 2025-07-02 | -1.60 |
| 2025-07-01 | -1.60 |
| 2025-06-30 | -1.61 |
| 2025-06-27 | -1.62 |
| 2025-06-26 | -1.64 |
| 2025-06-25 | -1.63 |
| 2025-06-24 | -1.63 |
| 2025-06-23 | -1.64 |
| 2025-06-20 | -1.64 |
| 2025-06-18 | -1.61 |
| 2025-06-17 | -1.61 |
| 2025-06-16 | -1.60 |
| 2025-06-13 | -1.18 |
| 2025-06-12 | -1.17 |
| 2025-06-11 | -1.20 |
| 2025-06-10 | -1.24 |
| 2025-06-09 | -1.20 |
| 2025-06-06 | -1.21 |
| 2025-06-05 | -1.20 |
| 2025-06-04 | -1.16 |
| 2025-06-03 | -1.15 |
| 2025-06-02 | -1.17 |
| 2025-05-30 | -1.14 |
| 2025-05-29 | -1.15 |
| 2025-05-28 | -1.14 |
| 2025-05-27 | -1.15 |
| 2025-05-23 | -1.15 |
| 2025-05-22 | -1.17 |
| 2025-05-21 | -1.20 |
| 2025-05-20 | -1.26 |
| 2025-05-19 | -1.25 |
| 2025-05-16 | -1.22 |
| 2025-05-15 | -1.17 |
| 2025-05-14 | -1.13 |
| 2025-05-13 | -1.17 |
| 2025-05-12 | -1.19 |
| 2025-05-09 | -1.16 |
| 2025-05-08 | -1.19 |
| 2025-05-07 | -1.21 |
| 2025-05-06 | -1.21 |
| 2025-05-05 | -1.27 |
| 2025-05-02 | -1.29 |
| 2025-05-01 | -1.32 |
| 2025-04-30 | -1.29 |
| 2025-04-29 | -1.34 |
| 2025-04-28 | -1.37 |
| 2025-04-25 | -1.38 |
| 2025-04-24 | -1.38 |